Metabolic
425 million adult people in the world are living with diabetes, with Type 2 diabetes accounting for 90% of all cases1
DISEASE AWARENESS
What is JARDIANCE® (empagliflozin)?
JARDIANCE® (empagliflozin) tablets are indicated as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes mellitus.
JARDIANCE® (empagliflozin) tablets are indicated to reduce the risk of cardiovascular death in adult patients with type 2 diabetes mellitus and established cardiovascular disease.
Important safety information
What is the most important information I should know about JARDIANCE® (empagliflozin)
Dehydration
Ketoacidosis
Urinary tract infections
Genital tract infections
Who should not use JARDIANCE® (empagliflozin)
Type 1 DM
Patients with persistent eGFR<45 ml/min/1.73 m2